We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03132675
Brief Title: Tavo and Pembrolizumab in Patients With Stage III/IV Melanoma Progressing on Pembrolizumab or Nivolumab Treatment (Keynote695)

First Submitted : April 24, 2017
First Submitted that Met QC Criteria : April 26, 2017
First Posted : April 28, 2017

Last Update Submitted that Met QC Criteria : February 14, 2022
Last Update Posted : February 15, 2022